Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Alterations in sleep, sleep spindle, and EEG power in mGluR5 knockout mice.

Aguilar DD, Strecker RE, Basheer R, McNally JM.

J Neurophysiol. 2019 Nov 20. doi: 10.1152/jn.00532.2019. [Epub ahead of print]

PMID:
31747354
2.

Somatostatin+/nNOS+ neurons are involved in delta electroencephalogram activity and cortical-dependent recognition memory.

Zielinski MR, Atochin DN, McNally JM, McKenna JT, Huang PL, Strecker RE, Gerashchenko D.

Sleep. 2019 Oct 9;42(10). pii: zsz143. doi: 10.1093/sleep/zsz143.

PMID:
31328777
3.

Thalamic Reticular Nucleus Parvalbumin Neurons Regulate Sleep Spindles and Electrophysiological Aspects of Schizophrenia in Mice.

Thankachan S, Katsuki F, McKenna JT, Yang C, Shukla C, Deisseroth K, Uygun DS, Strecker RE, Brown RE, McNally JM, Basheer R.

Sci Rep. 2019 Mar 5;9(1):3607. doi: 10.1038/s41598-019-40398-9.

4.

Optogenetic stimulation of basal forebrain parvalbumin neurons modulates the cortical topography of auditory steady-state responses.

Hwang E, Brown RE, Kocsis B, Kim T, McKenna JT, McNally JM, Han HB, Choi JH.

Brain Struct Funct. 2019 May;224(4):1505-1518. doi: 10.1007/s00429-019-01845-5. Epub 2019 Mar 2.

PMID:
30826928
5.

Validation of an automated sleep spindle detection method for mouse electroencephalography.

Uygun DS, Katsuki F, Bolortuya Y, Aguilar DD, McKenna JT, Thankachan S, McCarley RW, Basheer R, Brown RE, Strecker RE, McNally JM.

Sleep. 2019 Feb 1;42(2). doi: 10.1093/sleep/zsy218.

6.

Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalities.

McNally JM, McCarley RW.

Curr Opin Psychiatry. 2016 May;29(3):202-10. doi: 10.1097/YCO.0000000000000244. Review.

7.

Cortically projecting basal forebrain parvalbumin neurons regulate cortical gamma band oscillations.

Kim T, Thankachan S, McKenna JT, McNally JM, Yang C, Choi JH, Chen L, Kocsis B, Deisseroth K, Strecker RE, Basheer R, Brown RE, McCarley RW.

Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3535-40. doi: 10.1073/pnas.1413625112. Epub 2015 Mar 2. Erratum in: Proc Natl Acad Sci U S A. 2015 May 26;112(21):E2848.

8.

Comparative nonclinical assessments of the proposed biosimilar PF-05280014 and trastuzumab (Herceptin(®)).

Hurst S, Ryan AM, Ng CK, McNally JM, Lorello LG, Finch GL, Leach MW, Ploch SA, Fohey JA, Smolarek TA.

BioDrugs. 2014 Oct;28(5):451-9. doi: 10.1007/s40259-014-0103-4.

9.

Functional ryanodine receptors in the membranes of neurohypophysial secretory granules.

McNally JM, Custer EE, Ortiz-Miranda S, Woodbury DJ, Kraner SD, Salzberg BM, Lemos JR.

J Gen Physiol. 2014 Jun;143(6):693-702. doi: 10.1085/jgp.201311110.

10.

Reduction in cortical gamma synchrony during depolarized state of slow wave activity in mice.

Hwang E, McNally JM, Choi JH.

Front Syst Neurosci. 2013 Dec 16;7:107. doi: 10.3389/fnsys.2013.00107. eCollection 2013.

11.

Chronic Ketamine Reduces the Peak Frequency of Gamma Oscillations in Mouse Prefrontal Cortex Ex vivo.

McNally JM, McCarley RW, Brown RE.

Front Psychiatry. 2013 Sep 17;4:106. doi: 10.3389/fpsyt.2013.00106. eCollection 2013.

12.

Impaired GABAergic neurotransmission in schizophrenia underlies impairments in cortical gamma band oscillations.

McNally JM, McCarley RW, Brown RE.

Curr Psychiatry Rep. 2013 Mar;15(3):346. doi: 10.1007/s11920-012-0346-z. Review.

13.

Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia.

McNally JM, McCarley RW, McKenna JT, Yanagawa Y, Brown RE.

Neuroscience. 2011 Dec 29;199:51-63. doi: 10.1016/j.neuroscience.2011.10.015. Epub 2011 Oct 19.

14.

Individual calcium syntillas do not trigger spontaneous exocytosis from nerve terminals of the neurohypophysis.

McNally JM, De Crescenzo V, Fogarty KE, Walsh JV, Lemos JR.

J Neurosci. 2009 Nov 11;29(45):14120-6. doi: 10.1523/JNEUROSCI.1726-09.2009.

15.

Syntaxin 1A drives fusion of large dense-core neurosecretory granules into a planar lipid bilayer.

McNally JM, Woodbury DJ, Lemos JR.

Cell Biochem Biophys. 2004;41(1):11-24.

PMID:
15371637
16.

Bystander T cell activation and attrition.

McNally JM, Welsh RM.

Curr Top Microbiol Immunol. 2002;263:29-41. Review. No abstract available.

PMID:
11987818
17.

Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses.

McNally JM, Zarozinski CC, Lin MY, Brehm MA, Chen HD, Welsh RM.

J Virol. 2001 Jul;75(13):5965-76.

18.

Cutting edge: two distinct mechanisms lead to impaired T cell homeostasis in Janus kinase 3- and CTLA-4-deficient mice.

Gozalo-Sanmillan S, McNally JM, Lin MY, Chambers CA, Berg LJ.

J Immunol. 2001 Jan 15;166(2):727-30.

19.

Consequences of cross-reactive and bystander CTL responses during viral infections.

Welsh RM, McNally JM, Brehm MA, Selin LK.

Virology. 2000 Apr 25;270(1):4-8. Review. No abstract available.

20.

Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression.

Zarozinski CC, McNally JM, Lohman BL, Daniels KA, Welsh RM.

J Virol. 2000 Apr;74(8):3650-8.

21.

Diminished secondary CTL response in draining lymph nodes on cutaneous challenge with herpes simplex virus.

Jones CM, Cose SC, McNally JM, Jennings SR, Heath WR, Carbone FR.

J Gen Virol. 2000 Feb;81(Pt 2):407-14.

PMID:
10644839
22.

Immune deficiency, immune silencing, and clonal exhaustion of T cell responses during viral infections.

Welsh RM, McNally JM.

Curr Opin Microbiol. 1999 Aug;2(4):382-7. Review.

PMID:
10458980
24.

Phenotypic characteristics associated with the acquisition of HSV-specific CD8 T-lymphocyte-mediated cytolytic function in vitro.

McNally JM, Andersen HA, Chervenak R, Jennings SR.

Cell Immunol. 1999 May 25;194(1):103-11.

PMID:
10357886
25.

Differences in the recognition of CTL epitopes during primary and secondary responses to herpes simplex virus infection in vivo.

Nugent CT, McNally JM, Chervenak R, Wolcott RM, Jennings SR.

Cell Immunol. 1995 Oct 1;165(1):55-64.

PMID:
7545549
26.

Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies.

Wagner R, McNally JM, Bonifacio E, Genovese S, Foulis A, McGill M, Christie MR, Betterle C, Bosi E, Bottazzo GF.

Diabetes. 1994 Jul;43(7):851-6.

PMID:
7912208
27.

Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus.

Genovese S, Bonifacio E, McNally JM, Dean BM, Wagner R, Bosi E, Gale EA, Bottazzo GF.

Diabetologia. 1992 Apr;35(4):385-8.

PMID:
1516768
28.

Comparison of insulin autoantibodies in diabetes-related and healthy populations by precise displacement ELISA.

Dean BM, McNally JM, Bonifacio E, Jennings AM, Dunger DB, Gale EA, Bottazzo GF.

Diabetes. 1989 Oct;38(10):1275-81.

PMID:
2676657
29.

Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone.

Todd I, Pujol-Borrell R, Hammond LJ, McNally JM, Feldmann M, Bottazzo GF.

Clin Exp Immunol. 1987 Sep;69(3):524-31.

30.

Motion artifact suppression technique (MAST) for MR imaging.

Pattany PM, Phillips JJ, Chiu LC, Lipcamon JD, Duerk JL, McNally JM, Mohapatra SN.

J Comput Assist Tomogr. 1987 May-Jun;11(3):369-77.

PMID:
3571576
31.

Live as on a mountain--leadership, the great potential.

McNally JM.

J Prof Nurs. 1986 Nov-Dec;2(6):380-90. No abstract available.

PMID:
3641870
32.

Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes.

Dean BM, Becker F, McNally JM, Tarn AC, Schwartz G, Gale EA, Bottazzo GF.

Diabetologia. 1986 May;29(5):339-42.

PMID:
3522332
33.

In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.

Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PG, Gamble DR.

N Engl J Med. 1985 Aug 8;313(6):353-60.

PMID:
3159965
34.

Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus.

Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, Cudworth AG.

Lancet. 1981 Dec 19-26;2(8260-61):1363-5.

PMID:
6118756
35.
36.

Values: Part II.

McNally JM.

Superv Nurse. 1980 Jun;11(6):52-3. No abstract available.

PMID:
6901285
37.

Values: part I.

McNally JM.

Superv Nurse. 1980 May;11(5):27-30. No abstract available.

PMID:
6900405
38.

Leadership--the needed component.

McNally JM.

Nurs Leadersh. 1979 Sep;2(3):6-12. No abstract available.

PMID:
258297
39.

Be free, let me be me.

McNally JM.

Superv Nurse. 1979 Jul;10(7):30-2. No abstract available.

PMID:
256238
40.

The improvement of licensure results of minority B.S.N. students.

McNally JM.

J Nurs Educ. 1979 Jun;18(6):10-8. No abstract available.

PMID:
37218
41.

A resource model for continuing education in nursing.

McNally JM.

J Contin Educ Nurs. 1978 Jul-Aug;9(4):33-7. No abstract available.

PMID:
249322
42.

Loneliness and alone-ness in the administrator.

McNally JM.

Superv Nurse. 1978 Jan;9(1):28-9. No abstract available.

PMID:
245115
43.

The nurse leader-a caring administrator.

McNally JM.

Superv Nurse. 1977 Dec;8(12):47-9. No abstract available.

PMID:
244002
44.

Hurt and be healed.

McNally JM.

Superv Nurse. 1977 Apr;8(4):38-9. No abstract available.

PMID:
245790
45.

Gentleness--an attribute for administrators.

McNally JM.

Superv Nurse. 1976 Oct;7(10):70-1. No abstract available.

PMID:
1049159
46.

Is your number up? Ask the nurse!

McNally JM.

RN. 1975 Dec;38(12):43, 46, 48. No abstract available.

PMID:
1043119
47.

"Continuing education: a mandate for nurses".

McNally JM.

Nurs News. 1972 Dec;22(4):6-17. No abstract available.

PMID:
4486053
48.

Progress report on the ANA continuing education study.

McNally JM.

J Contin Educ Nurs. 1972 Jul-Aug;3(4):28-9. No abstract available.

PMID:
4485784
49.

Nurse power and certification.

McNally JM.

Tar Heel Nurse. 1969 Dec;31(4):56-64. No abstract available.

PMID:
5196590

Supplemental Content

Loading ...
Support Center